Nexiam (Esomeprazole)

Esomeprazole belongs to the proton pump inhibitor class. It binds irreversibly to the H+/K+ ATPase enzyme (the gastric proton pump) on the secretory surface of stomach parietal cells, blocking the final step of acid production. This inhibition lowers both basal and stimulated gastric acid output, raising gastric pH and allowing damaged tissue to heal.

The appropriate dose of Nexiam is determined by the prescribing healthcare professional based on the specific indication, patient characteristics, and clinical response. Dosage may vary for conditions such as GERD, ulcer disease, or Zollinger‑Ellison syndrome, and should follow the prescriber's instructions without deviation.

Safety data for esomeprazole in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should be consulted to evaluate individual circumstances before initiating therapy.

To request Nexiam, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and assistance with import documentation.

Nexiam (esomeprazole) offers similar efficacy to other PPIs such as omeprazole, lansoprazole, and pantoprazole in suppressing gastric acid. Some studies suggest esomeprazole may provide a slightly higher degree of acid control and a more consistent pharmacokinetic profile, but choice of agent often depends on individual patient response, tolerability and cost considerations.

Nexiam should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments. No refrigeration is required for this oral tablet formulation.

Nexiam is taken orally as a tablet. Swallow the tablet whole with a glass of water; it may be taken with or without food unless otherwise directed by the prescriber. Consistency in timing each day helps maintain stable acid suppression.

Serious but rare adverse events associated with esomeprazole include Clostridioides difficile‑associated colitis, acute interstitial nephritis, and severe hypersensitivity reactions such as rash, angioedema or anaphylaxis. Patients should seek immediate medical attention if they experience persistent diarrhea, unexplained kidney problems, or signs of an allergic reaction.

Nexiam should be avoided in individuals with known hypersensitivity to esomeprazole or any component of the formulation. Caution is also advised for patients with severe hepatic impairment, as metabolism may be affected. Consultation with a healthcare professional is essential before initiating therapy in these populations.